Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

442

Participants

Timeline

Start Date

June 30, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG

Co-Trimoxazole 960Mg Dispersible Tablet

Antibiotic prophylaxis of Spontaneous Bacterial Peritonitis

DRUG

Placebo oral tablet

Placebo

Trial Locations (1)

Royal Free hospital, Hampstead

All Listed Sponsors

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

University College, London

OTHER